Overview

A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function

Status:
Completed
Trial end date:
2019-08-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess how fast tirzepatide gets into the blood stream and how long it takes the body to remove it in participants with impaired kidney function compared to healthy participants.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Tirzepatide